Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arie Perry

Showing results (411-420 of 422) with videos related to

Pageof 43
Sort By:
Research Square|March 30, 2023
Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responsesDavid Raleigh, William Chen, Abrar Choudhury, et al.
Neuro-Oncology|January 22, 2026
Intracranial mesenchymal tumor, FET::CREB fusion-positive: an integrative analysis of 81 casesSharika Rajan, Hye-Jung Chung, Zhichao Wu, et al.
Neuro-Oncology|May 2, 2024
Meningioma: International Consortium on Meningiomas consensus review on scientific advances and treatment paradigms for clinicians, researchers, and patientsJustin Z Wang, Alexander P Landry, David R Raleigh, et al.
Acta Neuropathologica|February 14, 2023
Correction to: Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplificationMichaela-Kristina Keck, Martin Sill, Andrea Wittmann, et al.
Acta Neuropathologica|November 27, 2022
Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplificationMichaela-Kristina Keck, Martin Sill, Andrea Wittmann, et al.
Nature Medicine|November 9, 2023
Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responsesWilliam C Chen, Abrar Choudhury, Mark W Youngblood, et al.
Cancer Cell|March 22, 2014
Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibitionMarcel Kool, David T W Jones, Natalie Jäger, et al.
The Lancet. Oncology|May 14, 2018
Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohortSebastian M Waszak, Paul A Northcott, Ivo Buchhalter, et al.
Cell|February 27, 2016
New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETsDominik Sturm, Brent A Orr, Umut H Toprak, et al.
Cancer Cell|December 5, 2025
Advancing CNS tumor diagnostics with expanded DNA methylation-based classificationMartin Sill, Daniel Schrimpf, Areeba Patel, et al.
Pageof 43

Showing results (411-420 of 422) with videos related to

Sort By:
Pageof 43
Research Square|March 30, 2023
Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responsesDavid Raleigh, William Chen, Abrar Choudhury, et al.
Neuro-Oncology|January 22, 2026
Intracranial mesenchymal tumor, FET::CREB fusion-positive: an integrative analysis of 81 casesSharika Rajan, Hye-Jung Chung, Zhichao Wu, et al.
Neuro-Oncology|May 2, 2024
Meningioma: International Consortium on Meningiomas consensus review on scientific advances and treatment paradigms for clinicians, researchers, and patientsJustin Z Wang, Alexander P Landry, David R Raleigh, et al.
Acta Neuropathologica|February 14, 2023
Correction to: Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplificationMichaela-Kristina Keck, Martin Sill, Andrea Wittmann, et al.
Acta Neuropathologica|November 27, 2022
Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplificationMichaela-Kristina Keck, Martin Sill, Andrea Wittmann, et al.
Nature Medicine|November 9, 2023
Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responsesWilliam C Chen, Abrar Choudhury, Mark W Youngblood, et al.
Cancer Cell|March 22, 2014
Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibitionMarcel Kool, David T W Jones, Natalie Jäger, et al.
The Lancet. Oncology|May 14, 2018
Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohortSebastian M Waszak, Paul A Northcott, Ivo Buchhalter, et al.
Cell|February 27, 2016
New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETsDominik Sturm, Brent A Orr, Umut H Toprak, et al.
Cancer Cell|December 5, 2025
Advancing CNS tumor diagnostics with expanded DNA methylation-based classificationMartin Sill, Daniel Schrimpf, Areeba Patel, et al.
Pageof 43